SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-026876
Filing Date
2022-07-25
Accepted
2022-07-25 17:27:56
Documents
4
Period of Report
2022-08-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20004369x4_def14a.htm DEF 14A 647686
2 logo_firstwave.jpg GRAPHIC 117810
3 ny20004369x4_pc1x1.jpg GRAPHIC 733931
4 ny20004369x4_pc2x1.jpg GRAPHIC 644089
  Complete submission text file 0001140361-22-026876.txt   2708120
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37853 | Film No.: 221104402
SIC: 2834 Pharmaceutical Preparations